Dual-Role of Cholesterol-25-Hydroxylase in Regulating Hepatitis B Virus Infection and Replication

Qi Wei1,2, Hongxiao Song1, Yanli Gao3

  • 1Center for Pathogen Biology and Infectious Diseases, Department of Immunology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, the First Hospital of Jilin University, Changchun, Jilin, China.

Mbio
|May 19, 2022
PubMed

Insights

Cholesterol-25-hydroxylase (CH25H) expression is elevated in Hepatitis B virus (HBV) patients and inhibits HBV replication by interacting with HBx protein. This interaction blocks HBx nuclear translocation, revealing a novel host-virus crosstalk mechanism.

Area of Science:

  • Virology
  • Immunology
  • Biochemistry

Background:

  • Hepatitis B virus (HBV) causes millions of infections globally, posing a significant health challenge.
  • Cholesterol-25-hydroxylase (CH25H) and its product 25-hydroxycholesterol (25HC) show broad-spectrum antiviral activity, but their role in HBV is unknown.
  • Understanding host-virus interactions is crucial for developing effective HBV treatments.

Purpose of the Study:

  • To investigate the role of CH25H in regulating HBV infection and replication.
  • To identify CH25H mutants with retained antiviral activity but lacking hydroxylase function.
  • To elucidate the molecular mechanism of CH25H-mediated regulation of HBV.

Main Methods:

  • Compared CH25H expression in HBV-infected patients and healthy subjects.
  • Generated and analyzed CH25H mutants for antiviral activity and interaction with HBx.
  • Assessed the effect of CH25H and its mutants on HBx nuclear translocation and HBV replication.

Main Results:

  • CH25H expression was increased in HBV-infected patients and inversely correlated with HBV replication.
  • CH25H and its mutants interacted with HBx, inhibiting its nuclear translocation.
  • CH25H's interaction with HBx's C-terminal region and CH25H's transmembrane region 3 were critical for inhibiting HBV replication, independent of enzymatic activity.
  • 25HC promoted HBV infection but not replication.

Conclusions:

  • CH25H plays a dual role in regulating HBV, inhibiting replication via HBx interaction independently of its enzymatic activity.
  • The CH25H-HBx axis represents a novel host-virus crosstalk mechanism in HBV infection.
  • CH25H and its mutants are potential therapeutic targets for controlling HBV replication.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
709
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
169
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.4K
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
248
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
905